Cited by

• Autologous Stem Cell Transplant in Hodgkin's and Non-Hodgkin's Lymphoma, Multiple Myeloma, and AL Amyloidosis.

  Alnasser SM, Alharbi KS, Almutairy AF, Almutairi SM, Alolayan AM. Alnasser SM, et al. Cells. 2023 Dec 18;12(24):2855. doi: 10.3390/cells12242855. Cells. 2023. PMID: 38132175 Free PMC article. Review.
• Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients' monitoring after transplantation.

  Zamarin D, Giralt S, Landau H, Lendvai N, Lesokhin A, Chung D, Koehne G, Chimento D, Devlin SM, Riedel E, Bhutani M, Babu D, Hassoun H. Zamarin D, et al. Bone Marrow Transplant. 2013 Mar;48(3):419-24. doi: 10.1038/bmt.2012.151. Epub 2012 Aug 13. Bone Marrow Transplant. 2013. PMID: 22890289 Free PMC article.
• Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.

  Saad A, Mahindra A, Zhang MJ, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan AY, Kyle RA, Marks D, Nishihori T, Pasquini MC, Ramanathan M, Lonial S, Savani BN, Saber W, Sharma M, Sorror ML, Wirk BM, Hari PN. Saad A, et al. Biol Blood Marrow Transplant. 2014 Mar;20(3):402-408.e1. doi: 10.1016/j.bbmt.2013.12.557. Epub 2013 Dec 14. Biol Blood Marrow Transplant. 2014. PMID: 24342394 Free PMC article.
• Current status of autologous stem cell transplantation for multiple myeloma.

  Al Hamed R, Bazarbachi AH, Malard F, Harousseau JL, Mohty M. Al Hamed R, et al. Blood Cancer J. 2019 Apr 8;9(4):44. doi: 10.1038/s41408-019-0205-9. Blood Cancer J. 2019. PMID: 30962422 Free PMC article. Review.
• Is there an optimal timing of autologous stem-cell transplantation for multiple myeloma in the era of novel agents?

  Toprak SK. Toprak SK. Turk J Haematol. 2013 Sep;30(3):338-9. doi: 10.4274/Tjh.2013.0079. Epub 2013 Sep 5. Turk J Haematol. 2013. PMID: 24385820 Free PMC article. No abstract available.